Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
accrual, antidilutive, basic, bear, book, CEO, chairman, conform, cumulative, decision, dedicate, deferred, diagnostic, diffiuclt, diluted, enhanced, exit, flexibility, founder, greatest, growth, implementation, inclusion, leasehold, modification, molecule, program, proprietary, quality, ratably, reclassified, remaining, resource, retire, retirement, RVG, sharpen, shown, small, streamlining, structure, structured, system, therapy, unconditional, unmet
Removed:
acquire, acquired, beneficial, board, commence, conclusion, controlled, default, estimated, exclusive, exercise, FIN, GenStar, improved, indemnity, interpretation, June, legal, lender, manage, merger, purpose, Qualitative, Quantitative, repaying, responsible, schedule, servicing, study, tendered, trust, unpaid, Vascular, VGI
Filing tables
Filing exhibits
HGSI similar filings
Filing view
External links
Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)
I, Steven C. Mayer, Chief Financial Officer (principal financial officer) of Human Genome Sciences, Inc. (the “Registrant”), certify, to the best of my knowledge, based upon a review of the Quarterly Report on Form 10-Q for the period ended March 31, 2004 of the Registrant (the “Report”), that:
(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ Steven C. Mayer | ||||
Name: | Steven C. Mayer | |||
Date: | May 7, 2004 |